News

Early transcatheter aortic valve replacement reduces cardiovascular events in asymptomatic aortic stenosis patients
New analysis from the EARLY TAVR trial showed patients between the age of 65 and 70 years old derived the most benefits of a ...
Healio22h
Single antiplatelet therapy linked to reduced mortality after TAVR vs. dual
In a registry of patients who underwent transcatheter aortic valve replacement, those who had single antiplatelet therapy ...